Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cells

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of Health (R01CA095367-06, 2R01-CA-095045-06)
  • Prostate program of the Department of Defense Congressionally Directed Medical Research Programs (W81XWH-14-1-0608)
  • NCI Cancer Center (CA016056)
  • Prostate program of the Department of Defense Congressionally Directed Medical Research Programs (W81XWH-13-1-0276, PC121785)

This publication has 69 references indexed in Scilit: